Institutional Ownership
Agomab Therapeutics NV
CUSIP 00860C102SPONSORED ADSQ1 2026
Institutional Holders
32
13F filers
Shares Held
23.35M
Aggregate institutional
Institutional Value
$245.05M
Q1 2026
Net New Holders
+32
32 new · 0 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions32
Increased0
Decreased0
Sold out0
Institutional Holders
32 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Eqt Fund Management S.A R.L. | 5.14M | $53.94M | +5.14M | New |
| 2 | Sanofi | 2.78M | $29.19M | +2.78M | New |
| 3 | Cormorant Asset Management, LP | 2.47M | $25.86M | +2.47M | New |
| 4 | Tcg Crossover Management, LLC | 2.05M | $21.54M | +2.05M | New |
| 5 | Federated Hermes, Inc. | 1.62M | $16.97M | +1.62M | New |
| 6 | Casdin Capital, LLC | 1.55M | $16.26M | +1.55M | New |
| 7 | Andera Partners | 1.54M | $16.14M | +1.54M | New |
| 8 | Fmr LLC | 1.46M | $15.30M | +1.46M | New |
| 9 | Nantahala Capital Management, LLC | 1.20M | $12.85M | +1.20M | New |
| 10 | Aberdeen Group PLC | 707.7K | $7.42M | +707.7K | New |
22 more institutional holders on Premium
See every fund holding Agomab Therapeutics NV, with full quarter-over-quarter share changes.
Unlock all holders